Mirae Asset Global Investments Co., Ltd. Dynavax Technologies Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,908 shares of DVAX stock, worth $42,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,908
Previous 79,650
95.09%
Holding current value
$42,401
Previous $988,000
95.65%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DVAX
# of Institutions
259Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$238 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$118 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$102 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$86.4 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$77.5 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.37B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...